FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California (Reuters) -Shares of Grail fell as much as 13.7% in their market debut on Tuesday after being spun ...

Making in 2025. Grail Inc. (NASDAQ:GRAL) is one of the top performers. Grail Inc. soared by 379.5 percent in 2025, with the ...

Grail, a diagnostic biotech startup based in Menlo Park, Calif., has narrowed its focus to just one of the three cancer-detecting genomic blood tests it has developed in recent years, the company ...

Grail Inc. (NASDAQ:GRAL) is one of the best emerging technology stocks to invest in. On December 1, Morgan Stanley assumed ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. SAN DIEGO (CNS) – San Diego-based ...

MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced that detailed findings from the PATHFINDER study of ...

A sign at the front entrance to the global headquarters of Illumina is pictured in San Diego, California (Reuters) - Gene sequencing company Illumina said on Sunday it will divest cancer diagnostic ...

MENLO PARK, Calif., Feb. 25, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, has partnered with award-winning actress ...

Early-stage cancer detection startup Grail, which has investors including Amazon CEO Jeff Bezos, has filed to go public, according to a Sept. 9 CNBC report. 1. DNA-sequencing machine developer ...

CHICAGO -- Hundreds of people using the test company Grail were wrongly told they might have cancer, the company said in a statement Monday. Grail said a software glitch related to their telemedicine ...